NM_002163.4:c.813C>T

Variant summary

Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_002163.4(IRF8):​c.813C>T​(p.Phe271Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00397 in 1,608,418 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0036 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0040 ( 25 hom. )

Consequence

IRF8
NM_002163.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.152
Variant links:
Genes affected
IRF8 (HGNC:5358): (interferon regulatory factor 8) Interferon consensus sequence-binding protein (ICSBP) is a transcription factor of the interferon (IFN) regulatory factor (IRF) family. Proteins of this family are composed of a conserved DNA-binding domain in the N-terminal region and a divergent C-terminal region that serves as the regulatory domain. The IRF family proteins bind to the IFN-stimulated response element (ISRE) and regulate expression of genes stimulated by type I IFNs, namely IFN-alpha and IFN-beta. IRF family proteins also control expression of IFN-alpha and IFN-beta-regulated genes that are induced by viral infection. [provided by RefSeq, Jul 2008]
MIR6774 (HGNC:50202): (microRNA 6774) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 16-85918628-C-T is Benign according to our data. Variant chr16-85918628-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 542147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-85918628-C-T is described in Lovd as [Likely_benign]. Variant chr16-85918628-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.152 with no splicing effect.
BS2
High AC in GnomAd4 at 542 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IRF8NM_002163.4 linkc.813C>T p.Phe271Phe synonymous_variant Exon 7 of 9 ENST00000268638.10 NP_002154.1 Q02556

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IRF8ENST00000268638.10 linkc.813C>T p.Phe271Phe synonymous_variant Exon 7 of 9 1 NM_002163.4 ENSP00000268638.4 Q02556

Frequencies

GnomAD3 genomes
AF:
0.00356
AC:
542
AN:
152264
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000627
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00334
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0168
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00412
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.00340
AC:
813
AN:
239020
Hom.:
6
AF XY:
0.00328
AC XY:
431
AN XY:
131354
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00160
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000226
Gnomad SAS exome
AF:
0.000197
Gnomad FIN exome
AF:
0.0174
Gnomad NFE exome
AF:
0.00386
Gnomad OTH exome
AF:
0.00390
GnomAD4 exome
AF:
0.00402
AC:
5850
AN:
1456036
Hom.:
25
Cov.:
31
AF XY:
0.00397
AC XY:
2876
AN XY:
724628
show subpopulations
Gnomad4 AFR exome
AF:
0.000508
Gnomad4 AMR exome
AF:
0.00175
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000907
Gnomad4 SAS exome
AF:
0.000209
Gnomad4 FIN exome
AF:
0.0164
Gnomad4 NFE exome
AF:
0.00422
Gnomad4 OTH exome
AF:
0.00352
GnomAD4 genome
AF:
0.00356
AC:
542
AN:
152382
Hom.:
2
Cov.:
33
AF XY:
0.00396
AC XY:
295
AN XY:
74522
show subpopulations
Gnomad4 AFR
AF:
0.000625
Gnomad4 AMR
AF:
0.00333
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.0168
Gnomad4 NFE
AF:
0.00412
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.00319
Hom.:
0
Bravo
AF:
0.00243
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00382
EpiControl
AF:
0.00267

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

IRF8: BP4, BP7, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

not specified Benign:1
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency;C4016741:Immunodeficiency 32B Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.36
CADD
Benign
9.1
DANN
Benign
0.78

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs147080359; hg19: chr16-85952234; COSMIC: COSV51897701; COSMIC: COSV51897701; API